Paving technological gaps to transition into continuous bioprocessing of hPSC

Authors

• Daniel Komuczki, Novo Nordisk A/S, DenmarkFollow
• Léa Ledaine, Cell Therapy, Novo Nordisk A/S
• Monica Jara-Avaca, Cell Therapy, Novo Nordisk A/S
• Allan Ertmann Karlsen, Cell Therapy, Novo Nordisk A/S
• Dorthe Rønn-Petersen, Cell Therapy, Novo Nordisk A/S
• Mattias Hansson, Cell Therapy, Novo Nordisk A/S
• Manuel Quirós, Cell Therapy, Novo Nordisk A/S

Conference Dates

October 5-9, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Daniel Komuczki, Léa Ledaine, Monica Jara-Avaca, Allan Ertmann Karlsen, Dorthe Rønn-Petersen, Mattias Hansson, and Manuel Quirós, "Paving technological gaps to transition into continuous bioprocessing of hPSC" in "Integrated Continuous Biomanufacturing VII (ICB VII)", Irina Ramos, AstraZeneca; Mark Brower, Merck; Alois Jungbauer, BOKU; K. Brower, Sanofi Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/biomanufact_vii/65